Merck (MRK) Gains from Investment Securities (2009 - 2016)

Merck (MRK) has reported Gains from Investment Securities for 8 consecutive years, with $4.0 million the latest figure, recorded in Q4 2016.

• On a quarterly basis, Gains from Investment Securities fell 89.47% year-over-year to $4.0 million in Q4 2016; TTM through Dec 2016 was $16.0 million, a 68.0% decrease from a year earlier, with the FY2017 full-year figure at $2.0 million, down 87.5% from the prior year.
• Gains from Investment Securities was $4.0 million for Q4 2016 at Merck, down from $5.0 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $110.0 million in Q4 2012 and troughed at $3.0 million in Q1 2015.
• A 5-year average of $38.9 million and a median of $45.5 million in 2014 frame the typical range for Gains from Investment Securities.
• Across the five-year window, Gains from Investment Securities soared 1220.0% in 2014 and tumbled 95.45% in 2015, its largest moves.
• Over 5 years, Gains from Investment Securities stood at $110.0 million in 2012, then slumped by 46.36% to $59.0 million in 2013, then dropped by 10.17% to $53.0 million in 2014, then fell by 28.3% to $38.0 million in 2015, then tumbled by 89.47% to $4.0 million in 2016.
• The last three Gains from Investment Securities figures came in at $4.0 million (Q4 2016), $5.0 million (Q3 2016), and $3.0 million (Q2 2016), per Business Quant data.